Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a bio-pharmaceutical corporation established in 1979 and listed on the Shenzhen Stock Exchange in 2009. The company is dedicated to the development, manufacturing, and marketing of pharmaceuticals, with the aspiration to become one of the leading healthcare and pharmaceutical groups in China. Zhongsheng Pharma emphasizes sustainable growth through both endogenous development and strategic mergers and acquisitions, while also expanding into medical services and health management. Zhongsheng Pharma's operations encompass a diverse range of products in key therapeutic areas, including ophthalmology, gastroenterology, respiratory diseases, and cardiovascular and cerebrovascular diseases. The company is focused on addressing unmet clinical needs through innovative medicine research, particularly in areas such as MASH, organic fibrosis, neoplasm, and influenza. With a robust product library that includes generic drugs and a commitment to quality, Zhongsheng Pharma aims to support its growth and adapt to evolving market demands while adhering to national medication policies.

1.To support the strong, healthy, and steady growth of the corporation performance, Zhongsheng Pharma is in possession of a line of extensive products of a rational distribution and of various ranks, which comply closely with the latest national medication policy and aim at satisfying the overall sales demand. 2.The registered varieties of Quality Consistency Evaluation for Generic Drugs will become the supporting point of the new business volumes of Zhongsheng Pharma. 3.The generic drugs, the research projects of which are being conducted orderly and efficiently, will further expand the its product library and uphold the business performances of Zhongsheng Pharma. 4.A characteristic innovative product line shall lead Zhongsheng Pharma into a brighter and better future.